France· FR:62849957
EVEROLIMUS TEVA 5 mg, comprimé
A medicinal product containing évérolimus, registered in France by TEVA SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉVÉROLIMUS
- Manufacturer
- TEVA SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093011763730 plaquette(s) prédécoupée(s) unitaire(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)EUR 887.64
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Évérolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAFINITORNovartis Europharm Limited, Dublin
- NetherlandsAfinitor 5 mg, tablettenNovartis Europharm Limited
- United StatesAfinitorNovartis Pharmaceuticals Corporation
- SpainAFINITOR 5 MG COMPRIMIDOSNovartis Europharm Limited
- FinlandAfinitorNovartis Europharm Limited
- United KingdomAfinitor 5mg tabletsOriginalis B.V.
- SwedenAfinitor 5 mg TablettNovartis Europharm Limited
- PolandAfinitorNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Certican, Everolimus Ethypharm
- Belgium · Certican, Everolimus Eg
- Bulgaria · Еверолимус Крка, Еверолимус Майлан
- Cyprus · Certican, Everolimus Pharmazac
- Czechia · Certican, Everolimus Accord
- Germany · Certican, Everofin
- Denmark · Certican, Everolimus Krka
- Estonia · Certican, Everolimus Krka
- Spain · Certican, Everolimus Accord
- Finland · Aderolio, Certican
- United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
- Greece · Certican, Everolimus Faran
- Croatia · Certican, Everolimus Krka
- Hungary · Certican, Everolimus Accord
- Ireland · Certican, Everolimus Tad
- Iceland · Afinitor, Certican
- Italy · Certican, Everolimus Accord
- Liechtenstein · Afinitor, Votubia
- Lithuania · Certican, Everolimus Norameda
- Luxembourg · Certican, Everolimus Eg
- Latvia · Certican, Everolimus Norameda
- Malta · Certican, Everolimus Ascend
- Netherlands · Certican, Certican Dispers
- Norway · Afinitor, Certican
- Poland · Aderolio, Certican
- Portugal · Certican, Everolimus Ethypharm
- Romania · Certican, Everolimus Accord
- Sweden · Certican, Everolimus Avansor
- Slovenia · Certican, Everolimus Krka
- Slovakia · Certican, Everolimus Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4c359d6-a302-4f5a-9573-35e2044785f3 GET /v1/drugs/b4c359d6-a302-4f5a-9573-35e2044785f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62849957",
"date_amm": "2017-12-07",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ÉVÉROLIMUS",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about évérolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.